GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (STU:V9G0) » Definitions » Research & Development

XWELL (STU:V9G0) Research & Development : €0.00 Mil (TTM As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is XWELL Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. XWELL's Research & Development for the three months ended in Mar. 2024 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

XWELL Research & Development Historical Data

The historical data trend for XWELL's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XWELL Research & Development Chart

XWELL Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

XWELL Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

XWELL Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

XWELL  (STU:V9G0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

XWELL Research & Development Related Terms

Thank you for viewing the detailed overview of XWELL's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

XWELL (STU:V9G0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » XWELL Inc (STU:V9G0) » Definitions » Research & Development
Comparable Companies
NSTM ISPC NDRA SQL IDXG RNVA APDN PRPO BIAF DIGP TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
XWEL:USA
Address
254 West 31st Street, 11th Floor, New York, NY, USA, 10001
Website
https://www.xwell.com
XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresCheck, XpresSpa, Treat, and HyperPointe. XpresSpa is an airport retailer of wellness services and related products. Treat is a travel health and wellness brand that offers in-airport spa and wellness medical services. XpresCheck provides Covid-19 screening and diagnostic testing in partnership with the CDC. HyperPointe is a digital healthcare and data analytics relationship company.

XWELL (STU:V9G0) Headlines

No Headlines